Vivanza Biosciences Ltd

NSE: VIVANZA · BSE: 530057 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹1.70
Market cap: ₹6.80 Cr
Revenue (annual): ₹115.9 Cr
Net profit (annual): ₹0.39 Cr
P/E (TTM): 15.0×Sector 47.3×
Promoter holding: 20.02%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 5 Other Announcement 4 Financial Results 3 Management Change 2 Fund Raise 1 Debt & Borrowing 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

9 Apr 2026 12:39 IST BSE

Debt & Borrowing

Vivanza Biosciences Debt & Borrowing

Vivanza Biosciences Ltd confirmed it does not qualify as a 'Large Corporate' as of March 31, 2026, based on SEBI criteria. With zero outstanding borrowings, the company is exempt from the initial disclosure requirements for the financial year ended 2026.

Read the filing ↗